Qinlock (Ripretinib) Approved as Fourth-Line Treatment for GIST

MONDAY, May 18, 2020 — The U.S. Food and Drug Administration approved Qinlock (ripretinib) tablets as a fourth-line treatment for adults with advanced gastrointestinal stromal tumors (GISTs), the agency announced Friday. The approval follows four other FDA-approved target therapies for GIST, including imatinib in 2002, sunitinib in 2006, regorafenib in 2013, and avapritinib in January.… Read More: Qinlock (Ripretinib) Approved as Fourth-Line Treatment for GIST »

Reduce fat how long lasting

If you’ve lost weight, you likely know the blissful exhilaration of sliding into your skinny jeans, having a “you look slimmer” compliment boost your day, and discovering a newfound confidence — dare I say, sexiness. Don’t shoot the messenger: University of California, Los Angeles UCLA researchers analyzed 31 long-term studies and found people who lose… Read More: Reduce fat how long lasting »

Coronavirus: Half a million access suicide prevention course

More than half a million people have accessed online training that aims to prevent suicide in the last three weeks alone, a charity has said. The Zero Suicide Alliance said 503,000 users completed its online course during lockdown. It aims to help spot the signs that a person may need help. It comes as health… Read More: Coronavirus: Half a million access suicide prevention course »